Columbia Asset Management trimmed its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 1.3% in the fourth quarter, HoldingsChannel reports. The firm owned 7,595 shares of the company’s stock after selling 100 shares during the period. Columbia Asset Management’s holdings in Clorox were worth $1,234,000 at the end of the most recent reporting period.
A number of other hedge funds also recently modified their holdings of CLX. Brooklyn Investment Group raised its holdings in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares during the period. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the last quarter. Millstone Evans Group LLC bought a new position in shares of Clorox during the fourth quarter worth approximately $31,000. Asset Planning Inc acquired a new stake in Clorox during the 4th quarter worth approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in Clorox in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on CLX shares. Barclays dropped their target price on Clorox from $140.00 to $139.00 and set an “underweight” rating for the company in a report on Thursday, March 27th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus price target of $159.50.
Clorox Stock Up 0.4 %
NYSE CLX opened at $147.79 on Wednesday. The business has a fifty day moving average price of $150.83 and a two-hundred day moving average price of $158.74. The stock has a market capitalization of $18.21 billion, a PE ratio of 40.38, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the company posted $2.16 earnings per share. Equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.30%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is 133.33%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- What is a Bond Market Holiday? How to Invest and Trade
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- How to Invest in Insurance Companies: A Guide
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- How to Invest in the FAANG Stocks
- Buffett Trims Equities, But Still Keeps Buying This Stock
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.